{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:58:50Z","timestamp":1789408730472,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1053\/j.ajkd.2007.09.020","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T12:20:30Z","timestamp":1203682830000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Asymmetric Dimethylarginine and Lipid Peroxidation Products in Early Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1053","volume":"51","author":[{"given":"Dan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svend","family":"Strandgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene L.","family":"Borresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie G.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2007.09.020_bib1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0272-6386(12)80921-8","article-title":"Autosomal dominant polycystic kidney disease","volume":"22","author":"Gabow","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.09.020_bib2","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00004872-199715090-00002","article-title":"The pathogenesis of hypertension in autosomal dominant polycystic kidney disease","volume":"15","author":"Wang","year":"1997","journal-title":"J Hypertens"},{"key":"10.1053\/j.ajkd.2007.09.020_bib4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/hmg\/11.15.1731","article-title":"Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant","volume":"11","author":"Muto","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.ajkd.2007.09.020_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000025693","article-title":"Contractility and endothelium-dependent relaxation of resistance vessels in polycystic kidney rats","volume":"36","author":"Wang","year":"1999","journal-title":"J Vasc Res"},{"key":"10.1053\/j.ajkd.2007.09.020_bib6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.V1181371","article-title":"Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease","volume":"11","author":"Wang","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib7","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1046\/j.1523-1755.2003.00913.x","article-title":"Endothelial-derived vasoactive mediators in polycystic kidney disease","volume":"63","author":"Al-Nimri","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0463.2004.apm1120606.x","article-title":"The expression and activity of renal nitric oxide synthase and circulating nitric oxide in polycystic kidney disease rats","volume":"112","author":"Wang","year":"2004","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.1053\/j.ajkd.2007.09.020_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000094402","article-title":"Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease","volume":"26","author":"Clausen","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000101369","article-title":"Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function","volume":"27","author":"Borresen","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V131170","article-title":"Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease","volume":"13","author":"Kielstein","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/sj.ki.5000443","article-title":"Biochemical validation of a rat model for polycystic kidney disease: Comparison of guanidino compound profile with the human condition","volume":"69","author":"Torremans","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ki.5001632","article-title":"ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease","volume":"70","author":"Caglar","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib14","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2007.09.020_bib15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000063555","article-title":"Relationship between salt intake, nitric oxide and asymmetric dimethylarginine and its relevance to patients with end-stage renal disease","volume":"20","author":"Osanai","year":"2002","journal-title":"Blood Purif"},{"key":"10.1053\/j.ajkd.2007.09.020_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000078838","article-title":"Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition","volume":"27","author":"Kielstein","year":"2004","journal-title":"Kidney Blood Press Res"},{"key":"10.1053\/j.ajkd.2007.09.020_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1172\/JCI115849","article-title":"Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage","volume":"90","author":"Baylis","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2007.09.020_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ncpneph0143","article-title":"Arginine, arginine analogs and nitric oxide production in chronic kidney disease","volume":"2","author":"Baylis","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib19","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib20","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/sj.ki.5001983","article-title":"Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis","volume":"70","author":"Aslam","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1046\/j.1523-1755.2003.00768.x","article-title":"Endothelial dysfunction and inflammation in asymptomatic proteinuria","volume":"63","author":"Paisley","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00041552-200401000-00013","article-title":"Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension","volume":"13","author":"Valziri","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.ajkd.2007.09.020_bib24","doi-asserted-by":"crossref","first-page":"F1404","DOI":"10.1152\/ajprenal.00260.2006","article-title":"Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5\/6 nephrectomized rat","volume":"292","author":"Tain","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib25","doi-asserted-by":"crossref","first-page":"13527","DOI":"10.1073\/pnas.212269799","article-title":"S-Nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase","volume":"99","author":"Leiper","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ajkd.2007.09.020_bib26","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1074\/jbc.M209088200","article-title":"Zn(II)-free dimethylargininase-1 (DDAH-1) is inhibited upon specific Cys-S-nitrosylation","volume":"278","author":"Knipp","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2007.09.020_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.RES.87.2.99","article-title":"LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells","volume":"87","author":"Boger","year":"2000","journal-title":"Circ Res"},{"key":"10.1053\/j.ajkd.2007.09.020_bib28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00210-003-0756-x","article-title":"Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine","volume":"367","author":"Jiang","year":"2003","journal-title":"Arch Pharmacol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/cbic.200500527","article-title":"How to control NO production in cells: N(omega),N(omega)-dimethyl-l-arginine dimethylaminohydrolase as a novel drug target","volume":"7","author":"Knipp","year":"2006","journal-title":"Chembiochem"},{"key":"10.1053\/j.ajkd.2007.09.020_bib30","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/hc4601.098514","article-title":"Homocysteine impairs the nitric oxide synthase pathway","volume":"104","author":"St\u00fchlinger","year":"2001","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2007.09.020_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.fjc.0000159642.44523.7f","article-title":"Pravastatin restores DDAH activity and endothelium-dependent relaxation of rat aorta after exposure to glycated protein","volume":"45","author":"Yin","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1164\/ajrccm.156.4.12-tac-0","article-title":"Genetic analysis of a quantitative trait in a mouse model of polycystic kidney disease","volume":"156","author":"Iakoubova","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.ajkd.2007.09.020_bib33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1681\/ASN.V134991","article-title":"Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease","volume":"13","author":"Maser","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib34","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1681\/ASN.V881283","article-title":"Aggravation of polycystic kidney disease in Han:SPRD rats by buthionine sulfoximine","volume":"8","author":"Torres","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib35","first-page":"S78","article-title":"Identification of oxidatively modified lipids in atherosclerotic lesions of human aortas","volume":"37","author":"Belkner","year":"1992","journal-title":"Agents Actions Suppl"},{"key":"10.1053\/j.ajkd.2007.09.020_bib36","doi-asserted-by":"crossref","first-page":"16056","DOI":"10.1016\/S0021-9258(17)36198-7","article-title":"13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX","volume":"260","author":"Buchanan","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2007.09.020_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0009-3084(97)00070-4","article-title":"9-Hydroxy-10,12-octadecadienoic acid (9-HODE) and 13-hydroxy-9,11-octadecadienoic acid (13-HODE): Excellent markers for lipid peroxidation","volume":"89","author":"Spiteller","year":"1997","journal-title":"Chem Phys Lipids"},{"key":"10.1053\/j.ajkd.2007.09.020_bib38","first-page":"2131","article-title":"Chromium-51-EDTA clearance in adults with a single-plasma sample","volume":"39","author":"Martensson","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.ajkd.2007.09.020_bib39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00005344-198105000-00018","article-title":"Renal function, body fluid volumes, renin, aldosterone, and noradrenaline during treatment of hypertension with pindolol","volume":"3","author":"Wilcox","year":"1981","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib40","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/clinchem\/41.10.1414","article-title":"National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: Executive summary","volume":"41","author":"Bachorik","year":"1995","journal-title":"Clin Chem"},{"key":"10.1053\/j.ajkd.2007.09.020_bib41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2007.09.020_bib42","first-page":"147","article-title":"Separation of hydroxy and hydroperoxy polyunsaturated fatty acids by high-pressure liquid chromatography","volume":"108","author":"Browne","year":"1998","journal-title":"Methods Mol Biol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib43","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0022-3565(25)23163-9","article-title":"Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins","volume":"256","author":"Thomas","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/j.ajkd.2007.09.020_bib44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00007890-199603150-00013","article-title":"Increased serum nitric oxide concentration in cardiac transplantation patients","volume":"61","author":"Benvenuti","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2007.09.020_bib45","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/j.1440-1681.1996.tb03055.x","article-title":"Urinary NO\u22123 excretion as an indicator of nitrite oxide formation in vivo during oral administration of l-arginine and l-NAME in rats","volume":"23","author":"Boeger","year":"1996","journal-title":"Clin Exp Pharmacol Physiol Suppl"},{"key":"10.1053\/j.ajkd.2007.09.020_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0258(19960115)15:1<1::AID-SIM134>3.0.CO;2-E","article-title":"Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: A review","volume":"15","author":"Sahai","year":"1996","journal-title":"Stat Med"},{"key":"10.1053\/j.ajkd.2007.09.020_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.5414\/CNP61377","article-title":"Chronic kidney disease is associated with oxidative stress independent of hypertension","volume":"61","author":"Agarwal","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib48","doi-asserted-by":"crossref","first-page":"40449","DOI":"10.1074\/jbc.M104056200","article-title":"Structural and functional characterization of the Zn(II) site in dimethylargininase-1 (DDAH-1) from bovine brain","volume":"276","author":"Knipp","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2007.09.020_bib49","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1523-1755.2000.00380.x","article-title":"Renal expression of constitutive NOS and DDAH: Separate effects of salt intake and angiotensin","volume":"58","author":"Tojo","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib50","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/ndt\/17.11.1999","article-title":"Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans","volume":"17","author":"Nijveldt","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2007.09.020_bib51","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1681\/ASN.2005121379","article-title":"Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease","volume":"17","author":"Matsuguma","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib52","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1172\/JCI119761","article-title":"Macula densa arginine delivery and uptake in the rat regulates glomerular capillary pressure","volume":"100","author":"Welch","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2007.09.020_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00592310","article-title":"Molecular specificity of the l-arginine reabsorption mechanism","volume":"340","author":"Silbernagl","year":"1973","journal-title":"Pflugers Arch"},{"key":"10.1053\/j.ajkd.2007.09.020_bib54","first-page":"524","article-title":"NG, NG-dimethylarginine and NG, NG dimethylarginine in renal insufficiency","volume":"439","author":"Al","year":"2000","journal-title":"Pflugers Arch"},{"key":"10.1053\/j.ajkd.2007.09.020_bib55","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.ATV.0000128897.54893.26","article-title":"Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway","volume":"24","author":"Vallance","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib56","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.ATV.20.9.2032","article-title":"Does ADMA cause endothelial dysfunction?","volume":"20","author":"Cooke","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib57","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","article-title":"Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease","volume":"101","author":"Schachinger","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2007.09.020_bib58","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.09.020_bib59","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1992.413","article-title":"Renal histology in polycystic kidney disease with incipient and advanced renal failure","volume":"42","author":"Zeier","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib60","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.HYP.27.5.1165","article-title":"Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade","volume":"27","author":"Yamada","year":"1996","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2007.09.020_bib61","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/sj.ki.5001745","article-title":"Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress","volume":"70","author":"Schaufele","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.09.020_bib62","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860701428X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860701428X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:49:03Z","timestamp":1759456143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263860701428X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S027263860701428X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.09.020","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric Dimethylarginine and Lipid Peroxidation Products in Early Autosomal Dominant Polycystic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}